Cardiopulmonary Exercise Testing (CPET) In Adults: Difference between revisions
Anas Mohamed (talk | contribs) No edit summary |
Anas Mohamed (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
== Introduction == | == Introduction == | ||
'''Cardiopulmonary exercise testing (CPET)''' provides a global assessment of the integrative exercise responses involving the pulmonary, cardiovascular, hematopoietic, neuropsychological, and skeletal muscle systems, which are not adequately reflected through the measurement of individual organ system function. This relatively noninvasive, dynamic physiologic overview permits the evaluation of both submaximal and peak exercise responses, providing the physician with relevant information for clinical decision making. Once the exclusive province of research physiologists and specialized centers, CPET is increasingly being used in a wide spectrum of clinical applications for the evaluation of undiagnosed exercise intolerance and exercise-related symptoms, and for the objective determination of functional capacity and impairment. The use of CPET in patient management is increasing with the understanding that resting pulmonary and cardiac function testing cannot reliably predict exercise performance and functional capacity and that, furthermore, overall health status correlates better with exercise tolerance rather than with resting measurements.<ref>American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003 Jan 15;167(2):211-77. doi: 10.1164/rccm.167.2.211. Erratum in: Am J Respir Crit Care Med. 2003 May 15;1451-2. PMID: 12524257.</ref> | '''Cardiopulmonary exercise testing (CPET)''' provides a global assessment of the integrative exercise responses involving the pulmonary, cardiovascular, hematopoietic, neuropsychological, and skeletal muscle systems, which are not adequately reflected through the measurement of individual organ system function. This relatively noninvasive, dynamic physiologic overview permits the evaluation of both submaximal and peak exercise responses, providing the physician with relevant information for clinical decision making. Once the exclusive province of research physiologists and specialized centers, CPET is increasingly being used in a wide spectrum of clinical applications for the evaluation of undiagnosed exercise intolerance and exercise-related symptoms, and for the objective determination of functional capacity and impairment. The use of CPET in patient management is increasing with the understanding that resting pulmonary and cardiac function testing cannot reliably predict exercise performance and functional capacity and that, furthermore, overall health status correlates better with exercise tolerance rather than with resting measurements.<ref name=":0">American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003 Jan 15;167(2):211-77. doi: 10.1164/rccm.167.2.211. Erratum in: Am J Respir Crit Care Med. 2003 May 15;1451-2. PMID: 12524257.</ref> | ||
'''Cardiopulmonary exercise testing (CPET)''' is an examination that allows the investigator to simultaneously study the responses of the cardiovascular and ventilatory systems to a known exercise stress.This is possible because gas exchange at the airway is a consequence of cardiac output and pulmonary blood flow, as well as peripheral O2 extraction coupled to ventilation. Thus, the heart, with the circulation, couples gas exchanges (O2 and CO2) of muscle respiration with that at the lungs. The adequacy of the cardiovascular transport of O2 for known exercise work rates is described by the lung gas exchange.<ref>Karlman Wasserman. Principles of Exercise Testing and Interpretation Including Pathophysiology and Clinical Application. 5th edition. Wolters Kluwer Bussiness. 2012</ref> | '''Cardiopulmonary exercise testing (CPET)''' is an examination that allows the investigator to simultaneously study the responses of the cardiovascular and ventilatory systems to a known exercise stress.This is possible because gas exchange at the airway is a consequence of cardiac output and pulmonary blood flow, as well as peripheral O2 extraction coupled to ventilation. Thus, the heart, with the circulation, couples gas exchanges (O2 and CO2) of muscle respiration with that at the lungs. The adequacy of the cardiovascular transport of O2 for known exercise work rates is described by the lung gas exchange.<ref>Karlman Wasserman. Principles of Exercise Testing and Interpretation Including Pathophysiology and Clinical Application. 5th edition. Wolters Kluwer Bussiness. 2012</ref> | ||
| Line 30: | Line 30: | ||
* A non‐re breathing valve is connected to a mouthpiece to measure VO2 and (VCO2) and also prevent mixing of inspired and expired air | * A non‐re breathing valve is connected to a mouthpiece to measure VO2 and (VCO2) and also prevent mixing of inspired and expired air | ||
* Pulse oximetry to monitor oxygen saturation levels. | * Pulse oximetry to monitor oxygen saturation levels. | ||
== Indication == | |||
# Evaluation of Exercise Intolerance | |||
# Unexplained Dyspnea | |||
# Evaluation of Patients with Cardiovascular Disease | |||
# Evaluation of Patients with Respiratory Disease 216 | |||
#* Chronic Obstructive Pulmonary Disease (COPD) | |||
#* Interstitial Lung Disease (ILD) | |||
#* Chronic Pulmonary Vascular Disease (PVD) | |||
#* Cystic Fibrosis | |||
#* Exercise Induced Broncospasm (EIB) | |||
# Preoperative Evaluation 216 | |||
#* Preoperative Evaluation for Lung Cancer Resectional Surgery | |||
#* Lung Volume Reduction Surgery (LVRS) | |||
#* Evaluation for Lung or Heart-Lung Transplantation | |||
#* Preoperative Evaluation of Other Procedures | |||
# Exercise Prescription for Pulmonary Rehabilitation | |||
# Evaluation of Impairment/Disability<ref name=":0" /> | |||
== References == | == References == | ||
<references /> | <references /> | ||
Revision as of 09:30, 10 October 2020
Introduction[edit | edit source]
Cardiopulmonary exercise testing (CPET) provides a global assessment of the integrative exercise responses involving the pulmonary, cardiovascular, hematopoietic, neuropsychological, and skeletal muscle systems, which are not adequately reflected through the measurement of individual organ system function. This relatively noninvasive, dynamic physiologic overview permits the evaluation of both submaximal and peak exercise responses, providing the physician with relevant information for clinical decision making. Once the exclusive province of research physiologists and specialized centers, CPET is increasingly being used in a wide spectrum of clinical applications for the evaluation of undiagnosed exercise intolerance and exercise-related symptoms, and for the objective determination of functional capacity and impairment. The use of CPET in patient management is increasing with the understanding that resting pulmonary and cardiac function testing cannot reliably predict exercise performance and functional capacity and that, furthermore, overall health status correlates better with exercise tolerance rather than with resting measurements.[1]
Cardiopulmonary exercise testing (CPET) is an examination that allows the investigator to simultaneously study the responses of the cardiovascular and ventilatory systems to a known exercise stress.This is possible because gas exchange at the airway is a consequence of cardiac output and pulmonary blood flow, as well as peripheral O2 extraction coupled to ventilation. Thus, the heart, with the circulation, couples gas exchanges (O2 and CO2) of muscle respiration with that at the lungs. The adequacy of the cardiovascular transport of O2 for known exercise work rates is described by the lung gas exchange.[2]
CPET involves mainly the analysis of respiratory gases including.
- Respiratory oxygen uptake (Vo2),
- Carbon dioxide production (Vco2),
- Ventilatory measures during a symptom‐limited exercise test.
Purpose[edit | edit source]
- Diagnostic and prognostic evaluation of the cardiovascular and pulmonary diseases.
- Determination of the severity and functional effects of the disease
- Assessment for suitability of treatment, i.e. surgery, transplantation, supplemental oxygen therapy
- Determination of efficacy of therapeutic intervention
- Outcome variable for clinical trials
- Motivation and measurable goals to improve fitness
- Quantification of exercise rehabilitative training intensity
- Development of knowledge and understanding of the disease.
Technique[edit | edit source]
Cardiopulmonary exercise testing (CPET) can be assessed by Laboratory method (treadmill or bicycle ergometer)
Equipments[edit | edit source]
- Bicycle ergometer or Treadmill
- 12-ECG leads
- Non-invasive blood pressure cuffed monitoring
- A non‐re breathing valve is connected to a mouthpiece to measure VO2 and (VCO2) and also prevent mixing of inspired and expired air
- Pulse oximetry to monitor oxygen saturation levels.
Indication[edit | edit source]
- Evaluation of Exercise Intolerance
- Unexplained Dyspnea
- Evaluation of Patients with Cardiovascular Disease
- Evaluation of Patients with Respiratory Disease 216
- Chronic Obstructive Pulmonary Disease (COPD)
- Interstitial Lung Disease (ILD)
- Chronic Pulmonary Vascular Disease (PVD)
- Cystic Fibrosis
- Exercise Induced Broncospasm (EIB)
- Preoperative Evaluation 216
- Preoperative Evaluation for Lung Cancer Resectional Surgery
- Lung Volume Reduction Surgery (LVRS)
- Evaluation for Lung or Heart-Lung Transplantation
- Preoperative Evaluation of Other Procedures
- Exercise Prescription for Pulmonary Rehabilitation
- Evaluation of Impairment/Disability[1]
References[edit | edit source]
- ↑ 1.0 1.1 American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003 Jan 15;167(2):211-77. doi: 10.1164/rccm.167.2.211. Erratum in: Am J Respir Crit Care Med. 2003 May 15;1451-2. PMID: 12524257.
- ↑ Karlman Wasserman. Principles of Exercise Testing and Interpretation Including Pathophysiology and Clinical Application. 5th edition. Wolters Kluwer Bussiness. 2012
